Filter by: patients
Home > Community Treatment Reports and Side Effects > Efavirenz Treatment Report
What is Efavirenz?

Efavirenz is a nonnucleoside reverse transcriptase inhibitors (NNRTIs). Efavirenz is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your body. It is generally used in combination with at least two other antiretroviral agents.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 108 29 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Chills/fever 2 0
Support immune health 2 1 Efficacy_major
Don't know 1 0
General health 1 1 Efficacy_moderate
Idiopathic Thrombocytopenic Purpura 1 0

See all 82 patients currently taking Efavirenz

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 6
Moderate
 15
Mild
 9
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Efavirenz

Vivid dreams 18
Night sweats 8
Excessive sleeping (hypersomnia) 8
Hangover effect 6
Dehydration 4
Dizziness 3
See all 27 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

  daily 1 tbs. daily 3 tbs. daily 50 mg daily 100 mg daily 200 mg daily 300 mg daily 600 mg daily
  3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 64 Number of Patients: 64  

Reported Stop Reasons

Why Patients Stopped Taking Efavirenz (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 20   Doctor's advice: 36%
Side effects too severe 17   Side effects too severe: 30%
Other 14   Other: 25%
Course of treatment ended 6   Course of treatment ended: 11%
Did not seem to work 4   Did not seem to work: 7%
Personal research 4   Personal research: 7%
Expense 2   Expense: 4%
Change in health plan coverage 2   Change in health plan coverage: 4%
Not indicated 1   Not indicated: 2%

See all 55 patients who’ve stopped taking Efavirenz

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Efavirenz

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Efavirenz

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Efavirenz

Always
 28 90%
Usually
 3 10%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Efavirenz

Very
 2 6%
Somewhat
 3 10%
A little
 8 26%
Not at all
 18 58%

Cost

Paid out of pocket

Cost of Efavirenz

$200+
 2 11%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 6 33%
< $25
 10 56%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.